Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has…
NCT00003391 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00003391 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy |
| Official title | Phase I Trial of Monoclonal Antibody muJ591 in Patients With Hormone-Independent Prostate Cancer |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological |
| Interventions | monoclonal antibody muJ591 |
| Enrollment | 30 |
| Start date | Jun 1, 1998 |
| First posted | Jul 22, 2004 |
| Last update posted | Oct 12, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: